The D2dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder

European Psychiatry - Tập 21 - Trang 180-185 - 2006
Bruce R. Lawford1,2, Ross Young2,3, Ernest P. Noble2,4, Burnett Kann5, Terry Ritchie2
1Greenslopes Private Hospital, Brisbane, QLD, Australia
2Alcohol Research Centre, Neuropsychiatric Institute, UCLA, Los Angeles, CA, USA
3School of Psychology and Counselling, Queensland University of Technology, Carseldine, Brisbane, Qld., Australia
4Brain Research Institute, UCLA, Los Angeles, CA, USA
5Nambour Hospital, Nambour, Qld., Australia

Tóm tắt

AbstractObjective.

To identify clusters of patients with post-traumatic stress disorder (PTSD) according to symptom profile and to examine the association of the A1 allele of the D2dopamine receptor (DRD2) gene with these clusters.

Method.

Fifty-seven untreated Caucasian Vietnam veterans with PTSD were administered the General Health Questionnaire-28 (GHQ) and the Mississippi Scale for combat-related PTSD. DRD2 allelic status was determined by PCR.

Results.

Subjects with the DRD2 Al allele compared to those without this allele had significantly higher scores on GHQ 2 (anxiety/insomnia), GHQ 3 (social dysfunction) and GHQ 4 (depression). Cluster analysis of the GHQ data identified two primary groups. A high psychopathology cluster (cluster 3), featured by high co-morbid levels of somatic concerns, anxiety/insomnia, social dysfunction and depression, and a low psychopathology cluster (cluster 1), manifested by the reverse pattern. Scores in each of the four GHQ groups were significantly higher in cluster 3 than cluster 1, as was Mississippi Scale PTSD score. DRD2 A1 allele veterans compared to those without this allele were significantly more likely to be found in the high than the low psychopathology cluster group.

Conclusions.

DRD2 variants are associated with severe co-morbid psychopathology in PTSD subjects.


Tài liệu tham khảo

10.1016/S0920-9964(01)00185-2 10.1185/03007998209112376 10.1097/00004850-200008002-00007 10.1016/S0924-977X(02)00152-9 Kozaric-Kovacic, 2001, Posttraumatic stress disorder and depression in soldiers with combat experiences, Croat. Med. J, 42, 165 10.1037/1040-3590.15.2.205 10.2105/AJPH.93.4.624 10.1016/S0024-3205(97)01160-0 10.1176/appi.ajp.157.6.1019 10.1007/s002130050791 Everitt, 2001, Cluster analysis 10.1016/j.addbeh.2004.06.012 10.1192/bjp.165.1.60 10.1023/A:1025611208475 Bjelland, 1999, Anxiety and depression—a common mixture, Tidsskr. Nor. Laegeforen, 119, 3277 10.1016/S0165-1781(01)00296-7 10.1038/sj.mp.4000350 10.1038/nm0495-337 10.1023/B:BEGE.0000038487.80597.7e 10.1176/appi.ajp.158.2.327-a 10.1037/0735-7044.114.1.173 10.1093/hmg/2.12.2197-a 10.1002/(SICI)1096-8628(19991215)88:6<634::AID-AJMG11>3.0.CO;2-M 10.1097/00005053-200204000-00001 10.1385/JMN:14:1-2:077 10.1037/0022-006X.56.1.85 Kestler, 2000, The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised, Neuropsychiatry Neuropsychol. Behav. Neurol, 13, 48 10.1111/j.1749-6632.1997.tb51972.x 10.1016/S0925-4927(99)00009-8 10.1093/hmg/ddh239 10.1001/archpsyc.1991.01810310066012 10.1017/S0033291700005730 Pania, 2002, Dopaminergic deficit and mood disorders, Int. Clin. Psychopharmacol, S1 10.1176/ajp.154.12.1690 10.1097/00004714-200104000-00004 10.1176/appi.ajp.159.10.1675 Theohar, 1982, A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression, Arzneimittelforschung, 32, 783 10.1001/archpsyc.59.5.409 10.1001/archpsyc.1993.01820160019002 Volkow, 1999, Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels, Am. J. Psychiatry, 156, 1440, 10.1176/ajp.156.9.1440 10.1002/syn.10137 10.1016/0165-0327(81)90044-6 10.3109/00048679709073819 10.1038/sj.mp.4000532 10.1016/S0193-953X(02)00018-7 10.3109/00048679809062703 10.1016/S0006-3223(02)01383-5 10.1097/00008571-199712000-00006 10.1007/BF01277668